CAMBRIDGE, England, January 4, 2018 /PRNewswire/ -- If approved, BAREMSIS would be the first antiemetic with an indication for: - rescue treatment of PONV after failed prophylaxis, and - combination prophylaxis of PONV with standard antiemetics Acacia Pharma Grou...
from PR Newswire: //www.prnewswire.co.uk/news-releases/acacia-pharma-announces-fda-acceptance-of-nda-filing-for-baremsis-for-the-management-of-post-operative-667996253.html
No comments:
Post a Comment